Opucolimab

Product Name: Opucolimab
CAS No.: 2251771-79-4
Chemical Name: Opucolimab
Synonyms: Opucolimab;Research Grade Opucolimab;Research Grade Opucolimab (DHJ70109)
CBNumber: CB510616944
Formula Weight: 0
MOL File: Mol file

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

Opucolimab Chemical Properties,Usage,Production

Uses

Opucolimab is an anti-PD-L1 recombinant human monoclonal antibody. Opucolimab can be used to synthesis antibody agent conjugates. Opucolimab can be used for the research of advanced solid tumors[1].

References

[1] Xu, He, et al. Antibody drug conjugates. WO2022097117. 2022.

Opucolimab Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Opucolimab Suppliers

China 10 Global 10

ShangHai Biochempartner Co.,Ltd

Tel: 177-54423994 17754423994
Fax: QQ:2853530913
Email: 2853530910@QQ.com
Country: China
ProdList: 8000
Advantage: 62

Guangzhou Hongyuan Chemical Co.,Ltd

Tel: 15817493340
Email: 981810490@qq.com
Country: China
ProdList: 1566
Advantage: 58

Wuhan Chemstan Biotechnology Co., Ltd.

Tel: 027-65317797 15926423062
Fax: QQ：422450190
Email: 422450190@qq.com
Country: China
ProdList: 10308
Advantage: 58

Biolab Reagents

Tel: 027-65279366 18108604356
Email: products@biolabreagent.com
Country: China
ProdList: 9868
Advantage: 58

Nantong QuanYi Biotechnology Co., Ltd

Tel: 0513-66337626 18051384581
Email: sales@chemhifuture.com
Country: China
ProdList: 5927
Advantage: 58

Wanxin Biotechnology (Jiaxing) Co., LTD

Tel: 0573-83568680 18057391398
Email: 3956524501@qq.com
Country: China
ProdList: 1442
Advantage: 58

Atagenix Laboratories

Tel: 027-87008169 17762441161
Email: info@atagenix.com
Country: China
ProdList: 10001
Advantage: 58

AntibodySystem Laboratories SAS

Tel: 33175446423
Email: support@antibodysystem.com
Country: China
ProdList: 6739
Advantage: 58

Cell Sciences

Tel: 9785721070
Email: info@cellsciences.com
Country: China
ProdList: 6308
Advantage: 58

2251771-79-4, OpucolimabRelated Search:

Lacnotuzumab Loncastuximab Obiltoxaximab Berlimatoxumab Tidutamab Monoclonal antibody 6B1 igg4 Bezlotoxumab Flotetuzumab Demcizumab Alomfilimab

Opucolimab

Research Grade Opucolimab (DHJ70109)

Research Grade Opucolimab

2251771-79-4